Failure of the splicing variant p65 delta of the NF-kappa B subunit p65 to transform fibroblasts.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Oncogene

• Publication date

  1994-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8036023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Function and activation of NF-kappa B in the immune system.

  1994cited by this paper
• Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization.

  1993cited by this paper
• Nuclear uptake control of NF‐kappa B by MAD‐3, an I kappa B protein present in the nucleus.

  1993cited by this paper
• The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits.

  1993cited by this paper
• The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.

  1993cited by this paper
• Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.

  1993cited by this paper
• Hormone‐regulated v‐rel estrogen receptor fusion protein: reversible induction of cell transformation and cellular gene expression.

  1992cited by this paper
• NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats.

  1992cited by this paper
• Identification of a naturally occurring transforming variant of the p65 subunit of NF-kappa B.

  1992cited by this paper
• Failure of wild-type or a mutant form of protein kinase C-alpha to transform fibroblasts.

  1991cited by this paper
• DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition.

  1991cited by this paper
• Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts

  1991cited by this paper
• Malignant transformation by mutant Rel proteins.

  1991cited by this paper
• B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.

  1991cited by this paper
• Oncogenic transformation by vrel requires an amino-terminal activation domain

  1990cited by this paper
• The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.

  1990cited by this paper
• Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.

  1990cited by this paper
• The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

  1990cited by this paper
• Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines.

  1990cited by this paper
• A mutant protein kinase C that can transform fibroblasts

  1989cited by this paper
• Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression.

  1989cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper
• Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.

  1989cited by this paper
• The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.

  1988cited by this paper
• Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.

  1988cited by this paper
• Regional localization of the human c-rel locus using translocation chromosome analysis.

  1988cited by this paper
• Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.

  1987cited by this paper
• Activation of oncogenicity of the c-rel proto-oncogene

  1986cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Isolation of a transforming sequence from a human bladder carcinoma cell line.

  1982cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper
• Normal rat cell lines deficient in nuclear thymidine kinase.

  1981cited by this paper
• Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

  1977cited by this paper

• COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma

  2021cites this paper
• THE ROLE OF NF-KB ACTIVATION IN BREAST CARCINOMA AND GLIOBLASTOMA CELL LINES by

  2019cites this paper
• HCV core protein promotes heparin binding EGF‐like growth factor expression and activates Akt

  2011cites this paper
• Isolation of ORCTL3 in a novel genetic screen for tumor-specific apoptosis inducers

  2009cites this paper
• Roles and Regulation of NF-xB in Platelet-Derived Growth Factor Transformed Cells

  2002cites this paper
• Activation of NF-κB Is Required for PDGF-B Chain to Transform NIH3T3 Cells

  2002cites this paper
• Activation of NF-kappaB is required for PDGF-B chain to transform NIH3T3 cells.

  2002cites this paper
• Lack of p 65 / Nuclear Factor-Transformation Nonresponsive Cells Owe Their Resistance to Updated

  2001cites this paper
• Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.

  2001cites this paper
• Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts

  1997cites this paper
• Transcriptional regulation of the HOX4C gene by basic fibroblast growth factor on rheumatoid synovial fibroblasts.

  1997cites this paper
• Identification of a tumor-associated mutant form of the NF-κB RelA gene with reduced DNA-binding and transactivating activities

  1997cites this paper
• Rel/NF-kappa B and I kappa B factors in oncogenesis.

  1997cites this paper
• Rel Proteins and Their Inhibitors: A Balancing Act

  1997cites this paper
• NF-kappa B: ten years after.

  1996cites this paper
• Constitutive activation of NF‐kappa B is essential for transformation of rat fibroblasts by the human T‐cell leukemia virus type I Tax protein.

  1996cites this paper
• Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis

  1996cites this paper
• The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation.

  1996cites this paper
• Rel/NF-kappaB/IkappaB proteins and cancer.

  1996cites this paper
• NF-κB: Ten Years After

  1996cites this paper
• Retrovirus-mediated transfer of nuclear factor-kappa B subunit genes modulates I kappa B alpha and interferon beta expression.

  1995cites this paper
• Rel/NF-kappa B/I kappa B story.

  1995cites this paper
• Antagonism of nuclear factor-kappa B functions by steroid hormone receptors.

  1995cites this paper
• Retrovirus-mediated Transfer of Nuclear Factor-KB Subunit Genes Modulates licBu and Interferon 3 Expression'

  1995cites this paper